SCHEMBL7315428

SCHEMBL7315428

COC(=O)[C@H](Cc1ccc(NCc2ccc(OCC(=O)OC(C)(C)C)cc2)cc1)NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 2/20 0.50
ITGB1 P05556 4/20 0.47
ITGA5 P08648 3/20 0.47
KMT2A Q03164 1/20 0.46
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44
ITGAV P06756 1/20 0.43
HCRTR1 O43613 3/20 0.43
HCRTR2 O43614 3/20 0.43
CYP3A4 P08684 1/20 0.43
RAB9A P51151 1/20 0.42
KCNQ1 P51787 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 1/20 0.41
MMP1 P03956 1/20 0.41
ADAM17 P78536 1/20 0.41
FKBP1A P62942 1/20 0.41
YAP1 P46937 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710599 0.95 ITGA4 (0.54) ITGA4ITGB1ITGA5KMT2AMAPK1
SCHEMBL7455009 0.90 ITGA4 (0.48) ITGA4ITGB1ITGA5KMT2AMAPK1
SCHEMBL6714379 0.88 ITGA4 (0.60) ITGA4ITGB1ITGA5KMT2AITGAV
SCHEMBL6710652 0.87 ITGB1 (0.57) ITGA4ITGB1ITGA5MAPK1TSHR
SCHEMBL6709490 0.86 ITGA4 (0.54) ITGA4ITGB1ITGA5MAPK1TSHR
SCHEMBL7325830 0.85 ITGA4 (0.57) ITGA4ITGB1ITGA5KMT2AMAPK1
SCHEMBL7325073 0.84 ITGA4 (0.56) ITGA4ITGB1ITGA5KMT2AMAPK1
SCHEMBL7361018 0.83 ITGA4 (0.55) ITGA4ITGB1ITGA5RAB9AMMP1
SCHEMBL7446444 0.83 ITGA4 (0.61) ITGA4ITGB1ITGA5KMT2AMAPK1
SCHEMBL7348048 0.83 ITGB1 (0.53) ITGA4ITGB1ITGA5KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed